Dr. Jonathan Schneck is an IMAT-supported investigator from Johns Hopkins University. The IMAT grant program supports the development of novel technologies to further cancer research. Here, Dr. Schneck describes his group’s work on the development of a high-throughput system to analyze neoepitope-specific T-cell immune responses. Neoepitopes are features on the surface of the cell generated by mutations in the cancer cell that are recognized by T-cell receptors. By improving the ability to identify features specific to a patient’s disease, clinicians can create targeted treatments with immunotherapy-based approaches. This video is a testimonial from an IMAT-supported researcher that serves to highlight a success story from the program.
[ Ссылка ]
